Who Owns NRXP?

NRx Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings

$2.99

+0.08 (+2.75%)

Market Cap

$52.4M

Shares Outstanding

17,285,714

Institutional Holders

22

Total Inst. Value

$4.6M

% of Float Held

15.6%

QoQ Holder Change

Institutional data as of Q1 2025

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Anson Funds Management LP$2.4M1,179,061
2VANGUARD GROUP INC$797K388,925
3AdvisorShares Investments LLC$556K286,797
4GEODE CAPITAL MANAGEMENT, LLC$275K134,657
5MARSHALL WACE, LLP$183K89,086
6STATE STREET CORP$89K43,724
7TWO SIGMA INVESTMENTS, LP$62K30,146
8BlackRock, Inc.$60K29,075
9NORTHERN TRUST CORP$59K28,601
10One Wealth Management Investment & Advisory Services, LLC$31K15,041

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold NRXP?

As of Q1 2025, 22 institutional investors report holding NRXP (NRx Pharmaceuticals, Inc.) in their 13F filings.

What percentage of NRx Pharmaceuticals, Inc. is owned by institutions?

Institutional investors hold approximately 15.6% of NRx Pharmaceuticals, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most NRXP?

The largest institutional holder of NRXP is Anson Funds Management LP with $2.4M in shares.

Are institutions buying or selling NRXP?

This quarter, 7 institutions opened new positions in NRXP and 7 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.